Intrinsic Value of S&P & Nasdaq Contact Us

MoonLake Immunotherapeutics MLTX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • CH • USD

SharesGrow Score
49/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$25.25
+34.5%

MoonLake Immunotherapeutics (MLTX) has 11 known insider and institutional holders on record. The largest holder is Chen Bihua with 2,000,000 shares. Other notable holders include Bodenstedt Matthias and BVF PARTNERS L P/IL.

Over the last 12 months, insiders have made 23 transactions in MLTX stock — 10 buys (valued at $13.81M) and 8 sells (valued at $29.86M). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.

MLTX Insider Ownership

Top Holder
Chen Bihua
2,000,000 shares
Buys (12 mo)
10
$13.81M value
Sells (12 mo)
8
$29.86M value
12-Month Transaction Activity
Buy 43%
Sell 35%
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Chen Bihua Other: Former 10% Owner 2,000,000 2025-10-01
100%
2 Bodenstedt Matthias Chief Financial Officer 1,276,305 2026-01-09
64%
3 Bvf Partners L P/il 10 Percent Owner 1,039,238 2026-04-02
52%
4 Santos Da Silva Jorge Chief Executive Officer 520,342 2026-01-09
26%
5 Reich Kristian Chief Scientific Officer 520,342 2026-01-09
26%
6 Helix Holdings Llc 10 Percent Owner 430,000 2020-10-22
22%
7 Moukheibir Catherine Director 6,682 2025-06-09
0%
8 Xavier Ramnik Director 6,682 2025-06-09
0%
9 Loy Spike Director 6,682 2025-06-09
0%
10 Sturge Simon Director 6,682 2025-06-09
0%
11 Phillips Andrew John Director 6,682 2025-06-09
0%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2026-03-31 Bvf Partners L P/il 10 Percent Owner Informative Sell 248,530 $16.79 $4.17M
2026-01-07 Reich Kristian Chief Scientific Officer RSU Award 520,342 $11.29 $5.87M
2026-01-07 Bodenstedt Matthias Chief Financial Officer RSU Award 354,296 - -
2026-01-07 Santos Da Silva Jorge Chief Executive Officer RSU Award 520,342 $11.29 $5.87M
2025-12-19 Reich Kristian Chief Scientific Officer Return of Shares 35,389 - -
2025-12-19 Bodenstedt Matthias Chief Financial Officer Conversion (Sell) 8,754 - -
2025-12-19 Santos Da Silva Jorge Chief Executive Officer Return of Shares 196,316 - -
2025-12-09 Reich Kristian Chief Scientific Officer Informative Sell 72,908 $14.43 $1.05M
2025-12-08 Reich Kristian Chief Scientific Officer Informative Sell 130,000 $15.08 $1.96M
2025-12-09 Santos Da Silva Jorge Chief Executive Officer Informative Sell 70,000 $14.49 $1.01M
2025-12-08 Santos Da Silva Jorge Chief Executive Officer Informative Sell 130,000 $15.08 $1.96M
2025-10-08 Bodenstedt Matthias Chief Financial Officer Informative Buy 10,870 $9.09 $98.81K
2025-09-30 Chen Bihua Other: Former 10% Owner Informative Sell 5,827 $6.96 $40.56K
2025-09-29 Chen Bihua Other: Former 10% Owner Informative Sell 2,800,000 $6.61 $18.51M
2025-09-02 Reich Kristian Chief Scientific Officer Return of Shares 48,978 - -
2025-01-20 Reich Kristian Chief Scientific Officer Conversion (Sell) 1,456 - -
2025-07-03 Moukheibir Catherine Director Informative Sell 23,500 $48.79 $1.15M
2025-06-05 Phillips Andrew John Director RSU Award 6,682 $48.83 $326.28K
2025-06-05 Sturge Simon Director RSU Award 6,682 $48.83 $326.28K
2025-06-05 Xavier Ramnik Director RSU Award 6,682 $48.83 $326.28K
2025-06-05 Loy Spike Director RSU Award 6,682 $48.83 $326.28K
2025-06-05 Moukheibir Catherine Director RSU Award 6,682 $48.83 $326.28K
2025-06-05 Bvf Partners L P/il 10 Percent Owner RSU Award 6,682 $48.83 $326.28K
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message